-
China NMPA approves Antengene’ IND application for phase Ib/II study of ATG-022 in combo with Keytruda± chemotherapy
03 Dec 2025 12:39 GMT
… in combination with pembrolizumab and chemotherapy.
CLINCH-2 is a phase … with pembrolizumab plus the CAPOX chemotherapy regimen (A+P+C). The … in combination with pembrolizumab and chemotherapy in the frontline setting. In …
-
Major Australian discovery could improve chemotherapy
03 Dec 2025 09:34 GMT
… immortal" could improve chemotherapy and lead to new treatment … cells could help make chemotherapy work better, reduce side … DNA damage caused by chemotherapy, cancer cells can use … actin network could enhance chemotherapy effectiveness and might allow …
-
Ate Gay admitted to hospital after side effects from chemotherapy
03 Dec 2025 02:59 GMT
… experiencing side effects from his chemotherapy for his stage 4 cancer … successfully completed his 35-day chemotherapy sessions for his cancer.
At …
-
Akeso’s AK-135 relieves chemotherapy-induced pain
02 Dec 2025 22:35 GMT
… , for the potential treatment of chemotherapy-induced peripheral neuropathy.
BioWorld Science …
-
Scientists Disable Gene to Resensitize Lung Tumors to Chemotherapy
02 Dec 2025 14:08 GMT
… are better able to survive chemotherapy.
To counter this, researchers used … cells’ responsiveness to widely used chemotherapy drugs such as carboplatin and … and responded more effectively to chemotherapy.
“This work brings transformational change …
-
Major discovery could improve chemotherapy
02 Dec 2025 13:47 GMT
… understanding could help make chemotherapy work better, reduce side … DNA damage caused by chemotherapy. Chemotherapy is designed to kill … network, we could make chemotherapy much more effective,” she … need lower doses of chemotherapy, which would reduce harmful …
-
Eliminate cancer without surgery or chemotherapy: patient makes history and is treated with ultrasound capable of disintegrating tumors
02 Dec 2025 12:47 GMT
… disintegrating tumours, without surgery or chemotherapy.
Eliminate cancer without surgery or … chemotherapy: patient makes history and is …
-
Thymosin α1 Combined with PD-1/PD-L1 Inhibitor Plus Chemotherapy in Platinum-Resistant Recurrent Ovarian Cancer : A Retrospective Analysis
02 Dec 2025 07:39 GMT
… cases.1 Although platinum-based chemotherapy initially shows effectiveness, many … months, partly due to chemotherapy-induced immunosuppression limiting immune activation … effects of heated intraperitoneal chemotherapy can be augmented by thymosin …
-
Latent Profile Analysis of Flourishing in Patients Undergoing Chemotherapy After Ovarian Cancer Surgery: A Single-Center Study in Shanxi
02 Dec 2025 07:38 GMT
… multimodal therapies, including surgery, chemotherapy, immunotherapy, and targeted therapy … postoperative ovarian cancer undergoing chemotherapy and identified different … cancer patients receiving postoperative chemotherapy, prolonged treatment often induces …
-
<![CDATA[RATIONALE-305: Clinical Outcomes, Safety Profile, and Practical Use of Tislelizumab + Chemotherapy in Gastric/GEJ Adenocarcinoma]]>
01 Dec 2025 16:28 GMT
… in combination with platinum-based chemotherapy as first-line treatment for … 3 study, the tislelizumab plus chemotherapy arm achieved a median overall … about 12.9 months for chemotherapy alone in the intent-to …
About
© 1995-2025